IN2015DN04160A - - Google Patents
Download PDFInfo
- Publication number
- IN2015DN04160A IN2015DN04160A IN4160DEN2015A IN2015DN04160A IN 2015DN04160 A IN2015DN04160 A IN 2015DN04160A IN 4160DEN2015 A IN4160DEN2015 A IN 4160DEN2015A IN 2015DN04160 A IN2015DN04160 A IN 2015DN04160A
- Authority
- IN
- India
- Prior art keywords
- fatty alcohols
- pharmaceutically acceptable
- halobetasol
- acceptable carrier
- storage stable
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Abstract
Storage stable topical lotion compositions for treating corticosteroid responsive dermatoses are provided by the present invention which include a halobetasol material comprising halobetasol or its pharmaceutically acceptable salts esters and solvates; and a pharmaceutically acceptable carrier which includes: (a) one or more fatty alcohols and/or one or more alkoxylated fatty alcohols (b) one or more polyol humectants and (c) diisopropyl adipate. Storage stable topical lotion compositions for treating corticosteroid responsive dermatoses are provided by the present invention which include 0.05% halobetasol propionate; and a pharmaceutically acceptable carrier which includes: (a) one or more fatty alcohols and/or one or more alkoxylated fatty alcohols (b) one or more polyol humectants and (c) diisopropyl adipate.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261715467P | 2012-10-18 | 2012-10-18 | |
US13/921,859 US20140112959A1 (en) | 2012-10-18 | 2013-06-19 | Topical steroid composition and method |
US13/921,833 US8962028B2 (en) | 2012-10-18 | 2013-06-19 | Topical steroid composition and method |
PCT/US2013/065266 WO2014062817A1 (en) | 2012-10-18 | 2013-10-16 | Topical steroid composition and method |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2015DN04160A true IN2015DN04160A (en) | 2015-10-16 |
Family
ID=50485547
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN4160DEN2015 IN2015DN04160A (en) | 2012-10-18 | 2013-10-16 |
Country Status (20)
Country | Link |
---|---|
US (3) | US8962028B2 (en) |
EP (1) | EP2919753A1 (en) |
JP (1) | JP6385938B2 (en) |
KR (1) | KR101832041B1 (en) |
CN (1) | CN104884043B (en) |
AP (1) | AP2015008420A0 (en) |
AU (1) | AU2013331271B2 (en) |
BR (1) | BR112015008951A2 (en) |
CA (1) | CA2888853C (en) |
EA (1) | EA029494B1 (en) |
HK (1) | HK1214154A1 (en) |
IN (1) | IN2015DN04160A (en) |
MX (1) | MX371362B (en) |
MY (1) | MY179354A (en) |
NZ (1) | NZ706918A (en) |
PH (1) | PH12015500859A1 (en) |
SG (1) | SG11201502931YA (en) |
UA (1) | UA115073C2 (en) |
WO (1) | WO2014062817A1 (en) |
ZA (1) | ZA201502692B (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11957753B2 (en) | 2010-11-22 | 2024-04-16 | Bausch Health Ireland Limited | Pharmaceutical formulations containing corticosteroids for topical administration |
US8809307B2 (en) | 2010-11-22 | 2014-08-19 | Dow Pharmaceutical Sciences, Inc. | Pharmaceutical formulations containing corticosteroids for topical administration |
US10251895B2 (en) | 2015-06-18 | 2019-04-09 | Valeant Pharmaceuticals North America | Topical compositions and methods for treating psoriasis |
US11534382B2 (en) | 2017-06-19 | 2022-12-27 | Novan, Inc. | Topical compositions and methods of using the same |
WO2020181395A1 (en) | 2019-03-14 | 2020-09-17 | Crescita Therapeutics Inc. | Rinse-off compositions and uses thereof for delivery of active agents |
CN109833291B (en) * | 2019-04-03 | 2022-08-26 | 普霖贝利生物医药研发(上海)有限公司 | Stable clobetasol propionate ointment and preparation method thereof |
Family Cites Families (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2655570A1 (en) | 1975-12-12 | 1977-06-16 | Ciba Geigy Ag | NEW POLYHALOGSTEROIDS AND METHODS FOR THEIR PRODUCTION |
DE3225848A1 (en) * | 1982-07-07 | 1984-01-19 | Schering AG, 1000 Berlin und 4709 Bergkamen | PREPARATION OF CORTICOIDS FOR TOPICAL APPLICATION |
US5064655A (en) | 1989-02-24 | 1991-11-12 | Liposome Technology, Inc. | Liposome gel composition and method |
US5219877A (en) | 1989-09-25 | 1993-06-15 | Bristol-Myers Squibb Company | Lauryl alcohol as skin penetration enhancer for topical imidazole agents |
TW218849B (en) * | 1991-05-17 | 1994-01-11 | Bristol Myers Squibb Co | |
US5326566A (en) | 1991-05-17 | 1994-07-05 | Bristol-Myers Squibb Company | Use of dibutyl adipate and isopropyl myristate in topical and transdermal products |
CA2143515A1 (en) | 1994-03-22 | 1995-09-23 | Prakash Parab | Method for enhancing the rate of skin permeation of lactic acid through use of the l-enantiomer |
US6647058B1 (en) | 1997-06-23 | 2003-11-11 | Paradyne Corporation | Performance customization system and process for optimizing XDSL performance |
US6171985B1 (en) | 1997-12-01 | 2001-01-09 | 3M Innovative Properties Company | Low trauma adhesive article |
US6673374B2 (en) | 1998-07-31 | 2004-01-06 | Howard Murad | Pharmaceutical compositions and methods for managing skin conditions |
US6315980B1 (en) | 1998-09-25 | 2001-11-13 | Shiseido Company, Ltd. | Skin barrier function recovery and promotion composition and evaluation method thereof |
AU1803100A (en) * | 1999-01-06 | 2000-07-24 | Taisho Pharmaceutical Co., Ltd. | Amelometasone lotion |
US6495126B1 (en) | 1999-07-20 | 2002-12-17 | Mary Kay Inc. | Treatment and composition for achieving skin anti-aging benefits by corneum protease activation |
US6479058B1 (en) * | 1999-09-02 | 2002-11-12 | Mccadden Michael E. | Composition for the topical treatment of poison ivy and other forms of contact dermatitis |
US6656928B1 (en) | 1999-09-02 | 2003-12-02 | Mccadden Michael E. | Composition for the topical treatment of rashes, dermatoses and lesions |
US6967023B1 (en) | 2000-01-10 | 2005-11-22 | Foamix, Ltd. | Pharmaceutical and cosmetic carrier or composition for topical application |
US6756032B1 (en) | 2000-07-12 | 2004-06-29 | The Procter & Gamble Company | Method to enhance and/or prolong the effects of a primary challenge to a responsive system with a secondary challenge |
US6387383B1 (en) | 2000-08-03 | 2002-05-14 | Dow Pharmaceutical Sciences | Topical low-viscosity gel composition |
US6790203B2 (en) | 2000-12-20 | 2004-09-14 | Sca Hygiene Products Ab | Absorbent product comprising leakage barriers |
US6830758B2 (en) | 2001-04-02 | 2004-12-14 | Lectec Corporation | Psoriasis patch |
US6781027B2 (en) | 2001-12-14 | 2004-08-24 | Kimberly-Clark Worldwide, Inc. | Mixed denier fluid management layers |
US6765001B2 (en) * | 2001-12-21 | 2004-07-20 | Medicis Pharmaceutical Corporation | Compositions and methods for enhancing corticosteroid delivery |
US7704518B2 (en) | 2003-08-04 | 2010-04-27 | Foamix, Ltd. | Foamable vehicle and pharmaceutical compositions thereof |
US7208485B2 (en) | 2003-01-13 | 2007-04-24 | Chemagis Ltd. | Crystalline forms of halobetasol propionate |
US7186416B2 (en) | 2003-05-28 | 2007-03-06 | Stiefel Laboratories, Inc. | Foamable pharmaceutical compositions and methods for treating a disorder |
US8016811B2 (en) | 2003-10-24 | 2011-09-13 | Altea Therapeutics Corporation | Method for transdermal delivery of permeant substances |
WO2005065185A2 (en) * | 2003-12-24 | 2005-07-21 | Collegium Pharmaceuticals, Inc. | Temperature-stable formulations, and methods of development thereof |
NZ549159A (en) | 2004-02-19 | 2011-01-28 | Chemaphor Inc | Topical formulations for the treatment of skin conditions |
US8741333B2 (en) | 2004-06-07 | 2014-06-03 | Nuvo Research Inc. | Compositions and methods for treating dermatitis or psoriasis |
US20070196457A1 (en) | 2004-06-07 | 2007-08-23 | Jie Zhang | Two or more volatile solvent-containing compositions and methods for dermal delivery of drugs |
US20070189980A1 (en) | 2004-06-07 | 2007-08-16 | Jie Zhang | Compositions and methods for treating alopecia |
EP2377546B1 (en) | 2004-12-21 | 2016-11-02 | Musc Foundation For Research Development | Compositions and methods for promoting wound healing and tissue regeneration |
WO2006110534A2 (en) * | 2005-04-07 | 2006-10-19 | Taro Pharmaceuticals U.S.A., Inc. | A process for preparing a crystalline form of halobetasol propionate |
WO2008134013A2 (en) * | 2007-04-25 | 2008-11-06 | Teva Pharmaceutical Industries Ltd. | Pharmaceutical excipient complex |
US20100240621A1 (en) * | 2007-09-10 | 2010-09-23 | Glenmark Pharmaceuticals Ltd. | Topical pharmaceutical composition for the combination of fusidic acid and a corticosteroid |
CH701253A1 (en) | 2009-06-12 | 2010-12-15 | Mibelle Ag | Use of an extract from snow algae in cosmetic or dermatological formulations. |
US8809307B2 (en) | 2010-11-22 | 2014-08-19 | Dow Pharmaceutical Sciences, Inc. | Pharmaceutical formulations containing corticosteroids for topical administration |
-
2013
- 2013-06-19 US US13/921,833 patent/US8962028B2/en active Active
- 2013-06-19 US US13/921,859 patent/US20140112959A1/en not_active Abandoned
- 2013-10-16 NZ NZ706918A patent/NZ706918A/en not_active IP Right Cessation
- 2013-10-16 AU AU2013331271A patent/AU2013331271B2/en not_active Ceased
- 2013-10-16 MY MYPI2015701229A patent/MY179354A/en unknown
- 2013-10-16 CA CA2888853A patent/CA2888853C/en active Active
- 2013-10-16 WO PCT/US2013/065266 patent/WO2014062817A1/en active Application Filing
- 2013-10-16 MX MX2015004863A patent/MX371362B/en active IP Right Grant
- 2013-10-16 UA UAA201504666A patent/UA115073C2/en unknown
- 2013-10-16 CN CN201380066518.9A patent/CN104884043B/en not_active Expired - Fee Related
- 2013-10-16 EA EA201590730A patent/EA029494B1/en unknown
- 2013-10-16 IN IN4160DEN2015 patent/IN2015DN04160A/en unknown
- 2013-10-16 JP JP2015537793A patent/JP6385938B2/en active Active
- 2013-10-16 KR KR1020157012541A patent/KR101832041B1/en active IP Right Grant
- 2013-10-16 SG SG11201502931YA patent/SG11201502931YA/en unknown
- 2013-10-16 EP EP13795611.6A patent/EP2919753A1/en active Pending
- 2013-10-16 BR BR112015008951A patent/BR112015008951A2/en not_active Application Discontinuation
- 2013-10-16 AP AP2015008420A patent/AP2015008420A0/en unknown
-
2015
- 2015-01-09 US US14/593,272 patent/US20150119827A1/en not_active Abandoned
- 2015-04-17 PH PH12015500859A patent/PH12015500859A1/en unknown
- 2015-04-21 ZA ZA2015/02692A patent/ZA201502692B/en unknown
-
2016
- 2016-02-25 HK HK16102196.0A patent/HK1214154A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
BR112015008951A2 (en) | 2017-07-04 |
JP6385938B2 (en) | 2018-09-05 |
AU2013331271B2 (en) | 2017-09-28 |
ZA201502692B (en) | 2016-01-27 |
US20150119827A1 (en) | 2015-04-30 |
US20140112959A1 (en) | 2014-04-24 |
MX2015004863A (en) | 2016-02-05 |
JP2015534980A (en) | 2015-12-07 |
HK1214154A1 (en) | 2016-07-22 |
EA201590730A1 (en) | 2015-08-31 |
CN104884043A (en) | 2015-09-02 |
WO2014062817A1 (en) | 2014-04-24 |
EP2919753A1 (en) | 2015-09-23 |
US8962028B2 (en) | 2015-02-24 |
KR101832041B1 (en) | 2018-02-23 |
UA115073C2 (en) | 2017-09-11 |
CA2888853C (en) | 2019-02-12 |
PH12015500859B1 (en) | 2015-06-22 |
PH12015500859A1 (en) | 2015-06-22 |
EA029494B1 (en) | 2018-04-30 |
MX371362B (en) | 2020-01-27 |
CN104884043B (en) | 2018-12-11 |
MY179354A (en) | 2020-11-04 |
AU2013331271A1 (en) | 2015-05-07 |
CA2888853A1 (en) | 2014-04-24 |
AP2015008420A0 (en) | 2015-05-31 |
US20140112991A1 (en) | 2014-04-24 |
KR20150069005A (en) | 2015-06-22 |
NZ706918A (en) | 2019-01-25 |
SG11201502931YA (en) | 2015-05-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12015500859A1 (en) | Topical steroid composition and method | |
MX2021006035A (en) | Stable cannabinoid formulations. | |
PH12014501750A1 (en) | Pharmaceutical compositions containing dimethyl fumarate | |
EP4230264A3 (en) | Prodrugs of fumarates and their use in treating various deseases | |
WO2012145435A3 (en) | Systems and methods for spooling and unspooling linear material | |
WO2013158380A3 (en) | Hair care composition comprising metathesized unsaturated polyol esters | |
MX2018008012A (en) | Hair growth composition and method. | |
MX2016011841A (en) | Topical corticosteroid compositions. | |
EP3243821B8 (en) | Pharmaceutical formulations for regulating integrin cd11b/cd18 | |
IN2014DN07483A (en) | ||
RS54588B1 (en) | Liquid nasal spray containing low-dose naltrexone | |
IN2013CH05441A (en) | ||
WO2016085127A3 (en) | Stable peptide-conjugated ascorbic acid derivative, method for preparing same, and cosmetic composition containing same | |
WO2018013609A8 (en) | Synthetic melanin nanoparticles and uses thereof | |
NZ702934A (en) | Racecadotril lipid compositions | |
MX2015012345A (en) | Racecadotril lipid compositions. | |
EP3197498A4 (en) | Compositions containing ambient-temperature stable, inactivated but therapeutically active biopharmaceuticals&methods for formulation thereof | |
PH12014501866A1 (en) | Thermosensitive nanoparticle formulations and method of making the same | |
EP3196280A4 (en) | Composition containing eicosapentaenoic acid alkyl ester, and method for producing same | |
WO2014076568A3 (en) | Pharmaceutical compositions of cetp inhibitors | |
MD20150053A2 (en) | Co-micronisation product comprising ulipristal acetate | |
MX2016015211A (en) | Topical formulations and uses thereof. | |
IL225202A0 (en) | Box,rack,system and method for the presentation of products | |
EP3436513A4 (en) | Coalescing agent derived from succinate ester | |
MX2017010323A (en) | Pharmaceutical formulations of c1 esterase inhibitor. |